Novel Schizophrenia Drug Stumbles in Phase 3 Testing Novel Schizophrenia Drug Stumbles in Phase 3 Testing

The experimental oral antipsychotic known as Lu AF35700 was no more effective than conventional therapy in patients with treatment-resistant schizophrenia, according to new phase 3 study results.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news